Lonza has introduced an enhanced product line aimed at tackling concerns around bias during blinded clinical trials. Capsugel DBcaps double-blinded capsules are designed to be used as an over-encapsulation tool during clinical phases to overcome the challenges of blinding products during trials. Julien Lamps, Product Manager at Lonza said, “Capsugel DBcaps capsules have been specifically created to combat the main hurdles during double-blinded clinical trials. This opaque product has an exte...